Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
4,925 USD | +5,24% | +11,71% | +198,80% |
09/04 | Transcript : ADC Therapeutics SA - Special Call | |
04/04 | Sectorupdate: Gezondheidszorgaandelen dalen aan het eind van de middag | MT |
Omzet 2024 * | 80,92 mln. 75,65 mln. | Omzet 2025 * | 94,29 mln. 88,15 mln. | Marktkapitalisatie | 386 mln. 361 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -183 mln. -171 mln. | Nettowinst (verlies) 2025 * | -171 mln. -160 mln. | EV/omzet 2024 * | 5,49 x |
Nettoschuld 2024 * | 58,43 mln. 54,62 mln. | Nettoschuld 2025 * | 53,49 mln. 50,01 mln. | EV/omzet 2025 * | 4,66 x |
K/w-verhouding 2024 * |
-2,18
x | K/w-verhouding 2025 * |
-2,62
x | Werknemers | 274 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 65,63% |
Recentste transcriptie over ADC Therapeutics SA
1 dag | +6,73% | ||
1 week | +11,71% | ||
Lopende maand | +10,47% | ||
1 maand | +18,10% | ||
3 maanden | +151,78% | ||
6 maanden | +605,15% | ||
Lopend jaar | +198,80% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ameet Mallik
CEO | Chief Executive Officer | 51 | 09-05-22 |
Jose Carmona
DFI | Director of Finance/CFO | 51 | 19-12-22 |
Mohamed Zaki
CTO | Chief Tech/Sci/R&D Officer | 59 | 03-01-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Peter Hug
BRD | Director/Board Member | 65 | 01-06-19 |
Ron Squarer
CHM | Chairman | 57 | 01-04-20 |
Jean Bizzari
BRD | Director/Board Member | 69 | 01-07-22 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.02% | 0 M€ | 0,00% | - | |
0.02% | 0 M€ | 0,00% | - | |
0.01% | 2 M€ | -.--% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
23-04-24 | 5,01 | +7,05% | 89 085 |
22-04-24 | 4,68 | -0,85% | 173 368 |
19-04-24 | 4,72 | -0,84% | 646 031 |
18-04-24 | 4,76 | -4,03% | 278 551 |
17-04-24 | 4,96 | +11,71% | 1 272 321 |
uitgestelde koers Nyse, 23 april 2024 om 16:29 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+198,80% | 386 mln. | |
-0,53% | 103 mld. | |
+3,51% | 96,73 mld. | |
+1,48% | 21,31 mld. | |
-15,65% | 21,21 mld. | |
-6,26% | 18,79 mld. | |
-42,14% | 16,37 mld. | |
-21,61% | 13,68 mld. | |
+6,75% | 13,44 mld. | |
+23,86% | 10,98 mld. |